ORDR | GenomeWeb

ORDR

As part of the National Institutes of Health's Undiagnosed Diseases Program, researchers had sequenced about 50 exomes from 11 patients and their family members as of last month, as well as full genomes of three individuals. They have so far found disease-causing variants in two patients, and variants likely to be causative in another two.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.